Skip to main content
. Author manuscript; available in PMC: 2022 Oct 21.
Published in final edited form as: Arch Gynecol Obstet. 2021 Sep 25;305(1):87–93. doi: 10.1007/s00404-021-06208-2

Table 4.

Univariate and multivariate logistic regression comparing benign/CIN1–2 group and CIN3+ group

Variable Univariate Multivariate HPV Multivariate Screening Multivariate Demographics Multivariate Final
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
HPV-16 1.54 0.82 – 2.89 1.12 0.59 – 2.13 1.01 0.51 – 2.02
HPV-18 0.09 ** 0.01 – 0.63 0.09 ** 0.01 – 0.67 0.08 ** 0.01 – 0.65
HPV-HR Other 1.46 0.78 – 2.72
Prior Pap ASCUS or HSIL 1.29 0.67 – 2.52 1.67 0.79 – 3.58 1.28 0.56 – 2.91
Prior Procedure
Colposcopy 0.58 0.20 – 1.69 0.42 0.13 – 1.36 0.49 0.15 – 1.66
LEEP/CKC 0.83 0.28 – 2.48 0.65 0.20 – 2.06 0.65 0.19 – 2.19
Prior Screening Adequate 0.87 0.48 – 1.54 0.90 0.50 – 1.62 0.81 0.43 – 1.56
Age 0.99 0.96 – 1.03 0.99 0.96 – 1.02 0.99 0.96 – 1.02
Race
Black 0.38 0.05 – 2.91 0.27 0.03 – 2.35 0.30 0.03 – 2.86
Hispanic 0.34 0.04 – 2.60 0.28 0.04 – 2.23 0.32 0.04 – 2.67
Other 1.57 0.43 – 5.75 1.86 0.47 – 7.26 1.84 0.44 – 7.78
Medicaid/Medicare 0.82 0.35 – 1.94 1.01 0.40 – 2.52 1.00 0.38 – 2.61
BMI 1.03 0.99 – 1.07 1.04 * 1.00 – 1.09 1.05 * 1.00 – 1.10
Parity ≥1 2.16 ** 1.08 – 4.33 2.38 ** 1.16 – 4.89 2.23 ** 1.06 – 4.68
Smoking 0.45 0.13 – 1.52 0.46 0.13 – 1.59 0.50 0.14 – 1.79